Tripos Selects Three Recipients of Technology Award; International Competition Rewards High-Potential Research With Access to Compounds and Software for Rapid Drug Discovery
Tripos, Inc., a leading provider of drug discovery chemistry and informatics products and services, has announced the North American and European recipients of its Hits-to-Leads Awards Program. The three selected organizations and their areas of focus are these:
- Apath LLC, Missouri — broad-spectrum antiviral drug therapies
- Cancer Research UK — oncology therapies
- EntreMed Inc., Maryland — oncology therapies
Tripos’ Hits-to-Leads program grants proprietary products and services to overcome challenges faced by many researchers — lack of access to a wide array of compounds and the software to efficiently scan and track potential leads — without a major investment in infrastructure. “Our goal is to accelerate drug discovery with organizations that have proved their potential to find important medicines to improve the quality of human life,” said Dr. Peter Hecht, Ph.D., senior vice president of discovery research operations at Tripos.
Each recipient will receive diverse compounds, proprietary screening software and customized data analysis through the following products:
— LeadScreen(TM), 50,000 high-quality drug-like screening compounds
— SARNavigator(TM) , a desktop data-analysis technology
— Customized data analysis developed by Tripos’ scientists working closely with the winners
About Tripos, Inc.
Tripos (Nasdaq:TRPS) combines leading-edge technology and innovative science to deliver consistently superior chemistry-research products and services for the biotechnology, pharmaceutical and other life science industries. Tripos collaborates with clients to accelerate and improve the creation of life-enhancing products. Within Tripos’ Discovery Informatics (DI) business, the company provides software products and consulting services to develop, manage, analyze and share critical drug discovery information. Within Tripos’ Discovery Research (DR) business, Tripos’ medicinal chemists and research scientists partner directly with clients in their research initiatives, leveraging state-of-the-art information technologies and research facilities. Headquartered in St. Louis, Mo., Tripos spans the world with global research operations and an international client base. Further information on Tripos can be found at www.tripos.com .
